2026-02-16T16:38:31-06:00 2025-03-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2024-04-01 833947490 ROIVANT SOCIAL VENTURES INC ROIV 2128476204 1 PENNSYLVANIA PLAZA 54TH FL NEW YORK NY 10119 LINDSAY ANDROSKI PRESIDENT AND CEO 9146349551 2026-02-16 1 1 GINA RACHEL P01216293 2129498700 2024 2025-03-06 01:10:19Z X LINDSAY ANDROSKI 1 PENNSYLVANIA PLAZA 54TH FL NEW YORK NY 10119 306829 0 X WWW.ROIVANTSV.ORG X 2018 DE PROMOTE SYSTEMIC, SUSTAINED IMPROVEMENTS TO THE WAY HEALTHCARE IS ACCESSED AND DELIVERED. 5 0 0 47 0 0 110143 305032 0 0 13750 1797 0 0 123893 306829 0 23481 0 0 0 0 0 0 24010 254637 263754 254637 287235 -130744 19594 627351 408573 258804 24000 368547 384573 X SEE SCHEDULE OOUR MISSION IS TO IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS ON A NOT-FOR-PROFIT, CHARITABLE BASIS. WE USE INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. OUR WORK IS ACROSS TWO STRATEGIES: (I) INVESTMENTS AND INCUBATION LEADERSHIP TO EARLY-STAGE INNOVATIVE HEALTH ACCESS, MANUFACTURING, AND DRUG DEVELOPMENT ORGANIZATIONS WITH NO OR LOW-COST "PATIENT" CAPITAL AND RESOURCES; (II) CHARITABLE PARTNERSHIPS AND EDUCATIONAL INITIATIVES ACROSS INDUSTRY, PATIENT ADVOCACY, AND INVESTORS ACCELERATING DEVELOPMENT OF NEW MEDICINES. 0 0 163370 23481 SEE SCHEDULE OTHE ORGANIZATION HAD THE FOLLOWING INITIATIVES FOR THE FISCAL-YEARENDING MARCH 31, 2025:(I) TEACHING ROIVANT SOCIAL VENTURES' "MAKING MEDICINES" COURSE AT THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL'S ESHELMAN SCHOOL OF PHARMACY, THE NUMBER ONE RANKED PHARMACY SCHOOL IN THE UNITED STATES. WE DESIGNED AND LAUNCHED THIS INNOVATIVE COURSE IN 2023 TO INTRODUCE PHARMD STUDENTS TO THE NEW DRUG APPROVAL PROCESS AND KEY ISSUES IN DRUG DISCOVERY, PRE-CLINICAL TESTING, CLINICAL TRIALS, FDA APPROVAL, AND GLOBAL ACCESS TO MEDICINES. THE COURSE IS IN HIGH DEMAND AND RECEIVED MULTIPLE TEACHING AWARDS. (II) GROWING ROIVANT SOCIAL VENTURES' INAUGURAL ACCESS TO MEDICINES PHARMA INTERNSHIPS AND ACCESS TO MEDICINES GLOBAL FELLOWSHIPS FOR TALENTED PHARMD STUDENTS FROM GROUPS WITH DISPROPORTIONATE UNMET NEEDS IN MEDICINE. IN 2023 THE PROGRAM PROVIDED REAL-WORLD DRUG DEVELOPMENT EXPERIENCE TO FOUR HIGHLY QUALIFIED PHARMD STUDENTS. IN 2024 WE EXPANDED THE PROGRAM TO FIVE STUDENTS. (III) CONTINUING OUR THOUGHT LEADERSHIP CAMPAIGN THROUGH HOSTING EVENTS LIKE "INCREASING IMPACT: LEVERAGING DATA TO DRIVE HEALTHCARE ACCESS AND ADVANCEMENT," THAT PROVIDED INCREASED VISIBILITY AND EDUCATION ON ISSUES IN HEALTHCARE ACCESS, AND SPEAKING AT EVENTS WITH ORGANIZATIONS LIKE THE TERMEER FOUNDATION, BIO'S CEO AND INVESTOR CONFERENCE, THE ADVANCING WOMEN'S LEADERSHIP IN PHARMA AND HEALTHCARE CONFERENCE, THE NATIONAL VACCINE LAW CONFERENCE, AND 50/50 WOMEN ON BOARDS. (IV) LAUNCHED OUR INAUGURAL CONVERGENCE FORUM FELLOWSHIPS, WHICH PROVIDED SUPPORT FOR HIGHLY TALENTED FIRST-TIME FEMALE AND UNDERREPRESENTED CEOS TO ATTEND AN INTIMATE, INVITATION ONLY CONFERENCE OF PROMINENT HEALTHCARE LEADERS.(V) LAUNCHING OUR HEALTH EQUITY SPOTLIGHT SERIES, WHICH HIGHLIGHTS ORGANIZATIONS INCREASING ACCESS TO RESEARCH, MEDICINE, AND MEDICAL CARE FOR UNDERSERVED PATIENT GROUPS. 163370 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 6 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 5 0 1 0 0 0 1 1 0 1 0 0 0 1 1 0 0 1 1 0 0 0 NY X AMANDA WALDHAUSER 8472091020 1 PENNSYLVANIA PLAZA 54TH FL NEW YORK NY 10119 ERIC VENKER DIRECTOR 0.20 49.80 X 0 16220093 5162135 MATTHEW GLINE DIRECTOR AND SECRETARY 0.20 49.80 X X 0 24803978 185851159 RAKHI KUMAR TO 22025 DIRECTOR AND TREASURER 0.20 49.80 X X 0 4037660 2058756 DANIEL PATTERSON DIRECTOR 0.20 49.80 X 0 1567059 420313 LINDSAY ANDROSKI DIRECTOR, PRESIDENT AND CEO 4.00 46.00 X X 0 1110342 49318 0 47739132 193541681 0 0 1 0 WALDHAUSER & ASSOCIATES STRATEGIC ADVISI 1208 HULL TERRACE EVANSTON IL 60202 BUSINESS CONSULTING 159293 1 305032 305032 1797 1797 306829 0 0 1797 23481 23481 168725 122527 42500 3698 4990 4990 56920 56920 411 411 8438 8438 3934 3934 PUBLICATION/SUBSCRIPT. 20336 24 20312 287235 163370 99855 24010 337602 398756 36224 9817 250000 3525 0 627351 408573 8804 24000 250000 258804 24000 X 368547 384573 368547 384573 627351 408573 X 19594 -3568 X 1 X 0 0 0 X 23041 684276 170136 110143 305032 1292628 23041 684276 170136 110143 305032 1292628 167753 1124875 9516 12957 13750 1797 38020 1330648 0.84540 0.80990 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE-LIKELY-THAN-NOT BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION. THE ORGANIZATION IS NO LONGER SUBJECT TO AUDITS BY THE APPLICABLE TAXING JURISDICTIONS FOR PERIODS PRIOR TO 2022. CURRENTLY, THERE ARE NO AUDITS IN PROGRESS. 1 FELLOWSHIPS 2 23481 PART I, LINE 2: THE ORGANIZATION MONITORED THE USE OF GRANT/FELLOWSHIP FUNDING AND PARTICIPATION THROUGH HAVING EACH GRANT RECIPIENT: 1. PARTICIPATE IN AN INITIAL ONBOARDING MEETING WITH RSV; 2. PARTICIPATE IN AN INFORMATIONAL INTERVIEW WITH RSV THAT WILL BE LEVERAGED TO CREATED A HIGHLIGHT PIECE ON THE FELLOWSHIP WITHIN RSV'S COMMUNICATIONS; 3. PRESENT ON THEIR EXPERIENCE ON BEHALF OF RSV IN NEW YORK CITY IN JULY OF 2025; AND 4. PARTICIPATE IN A FOLLOW UP INTERVIEW WITH RSV. PART III, LINE 1 DURING FISCAL YEAR 2025, RSV AWARDED FELLOWSHIPS TO TWO INDIVIDUALS TO SUPPORT TRAVEL, LIVING AND OTHER EXPENSES INCURRED WHILE PROVIDING EIGHT WEEKS OF VOLUNTEER SERVICE AT A COMMUNITY PHARMACY CHAIN IN RWANDA. 0 0 1 0 0 0 0 0 0 MATTHEW GLINE DIRECTOR AND SECRETARY 0 725000 0 4293750 0 19785228 0 185812067 0 39092 0 210655137 0 0 ERIC VENKER DIRECTOR 0 570000 0 5598750 0 10051343 0 5136303 0 25832 0 21382228 0 0 RAKHI KUMAR TO 22025 DIRECTOR AND TREASURER 0 383438 0 1025789 0 2628433 0 2058756 0 0 0 6096416 0 317650 DANIEL PATTERSON DIRECTOR 0 290857 0 589014 0 687188 0 410061 0 10252 0 1987372 0 184832 LINDSAY ANDROSKI DIRECTOR, PRESIDENT AND CEO 0 312113 0 515653 0 282576 0 25766 0 23552 0 1159660 0 162134 PART I, LINE 3: NO OFFICER IS COMPENSATED BY THE ORGANIZATION. PART I, LINES 4B-C WHILE NO OFFICER IS COMPENSATED BY THE FILING ENTITY, OFFICERS HAVE BEEN COMPENSATED FOR THEIR WORK FOR A RELATED ENTITY THAT IS CONSIDERED A BROTHER/SISTER TO THE FILING ENTITY. THE RELATED ENTITY HAS BOTH A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN AND EQUITY BASED COMPENSATION ARRANGEMENT FOR ITS EMPLOYEES, AS HAS BEEN DISCLOSED IN PART II. ROIVANT SCIENCES LTD CREATOR TO ENABLE RSV TO FUND A LOAN TO AN UNRELATED ENTITY TO SUPPORT ITS PROGRAM X 250000 0 1 1 FORM 990, PART VI, SECTION A, LINE 2 EACH OF THE OFFICERS AND DIRECTORS ARE EMPLOYED BY ROIVANT SCIENCES INC., A WHOLLY CONTROLLED ENTITY OF ROIVANT SCIENCES LTD., ROIVANT SOCIAL VENTURES, INC.'S (THE ORGANIZATION") SOLE MEMBER. FORM 990, PART VI, SECTION A, LINE 6 ROIVANT SOCIAL VENTURES, INC. HAS A SOLE MEMBER: ROIVANT SCIENCES LTD. FORM 990, PART VI, SECTION A, LINE 7A AS THE SOLE MEMBER, ROIVANT SCIENCES LTD. HAS THE RIGHT TO: (I) APPROVE THE ELECTION OF DIRECTORS; (II) APPROVE THE NUMBER OF DIRECTORS COMPRISING THE BOARD OF DIRECTORS; (III) REMOVE DIRECTORS WITH OR WITHOUT CAUSE; (IV) APPROVE ANY AMENDMENT TO THE CERTIFICATE OF INCORPORATION OR BYLAWS OF THE CORPORATION ADOPTED BY THE BOARD OF DIRECTORS; (V) APPROVE THE MERGER, SALE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS, DOMESTICATION, CONVERSION OR DISSOLUTION OF THE CORPORATION, IN EACH CASE AS ADOPTED BY THE BOARD OF DIRECTORS; AND (VI) VOTE FOR SUCH OTHER MATTERS AS MAY BE PROVIDED IN THESE BYLAWS OR THE PROVISIONS OF THE DELAWARE GENERAL CORPORATION LAW. FORM 990, PART VI, SECTION A, LINE 8B GIVEN THE SIZE OF THE ORGANIZATION'S BOARD OF DIRECTORS, THERE ARE NO FORMAL COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED AND APPROVED BY THE ORGANIZATION'S PRESIDENT AND CEO PRIOR TO FILING. THE BOARD OF DIRECTORS ARE PROVIDED A COPY OF THE 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION HAS NO EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: LOSS ON UNCOLLECTIBLE AMOUNTS -3,568. AFFIVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 981565911 SCIENTIFIC R&D SZ HEMAVANT SCIENCES GMBH C 0 AFFIVANT SCIENCES HOLDINGS LIMITED 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981565694 HOLDING COMPANY UK AFFIVANT SCIENCES LTD C 0 AFFIVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONG UK SWIH 0DB 981565414 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 ALYVANT LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981494184 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 ARUVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 SCIENTIFIC R&D SZ HEMAVANT SCIENCES GMBH C 0 ARUVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981490198 SCIENTIFIC R&D UK ROIVANT SCIENCES LTD C 0 CLARIVANT INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 333237676 SCIENTIFIC R&D NY ROIVANT SCIENCES LTD C 0 COVANT THERAPEUTICS OPERATING INC 1111B S GOVERNORS AVE DOVER DE 19904 922630605 SCIENTIFIC R&D DE ROIVANT SCIENCES LTD C 0 GENEVANT SCIENCES BIOVENTURES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 SCIENTIFIC R&D SZ GENEVANT SCIENCES GMBH C 0 GENEVANT SCIENCES CORPORATION 887 GRAND NORTHERN WAY VANCOUVER BRITISH COLUMBIA CA V6C 3L6 981486273 SCIENTIFIC R&D CA GENEVANT SCIENCES HOLDINGS LIMITED C 0 GENEVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 981468560 SCIENTIFIC R&D SZ GENEVANT SCIENCES HOLDINGS LIMITED C 0 GENEVANT SCIENCES HOLDINGS LIMITED 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981466897 HOLDING COMPANY UK GENEVANT SCIENCES LTD C 0 GENEVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 371927500 SCIENTIFIC R&D UK ROIVANT SCIENCES LTD C 0 GENEVANT SCIENCES INC 245 MAIN ST 2ND FL CAMBRIDGE MA 02142 824617869 MANAGING OFFICES MA GENEVANT SCIENCES HOLDINGS LIMITED C 0 HAYSTACK HEALTH HOLDINGS COMPANY 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 920427479 HOLDING COMPANY NY ROIVANT SCIENCES LTD C 0 HAYSTACK HEALTH COMPANY 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 920401356 BIOTECHNOLOGY R&D NY HAYSTACK HEALTH HOLDINGS COMPANY C 0 HEKAHEART HOLDINGS INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 932552859 HOLDING COMPANY NY ROIVANT SCIENCES LTD C 0 HEKAHEART INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 932585341 SCIENTIFIC R&D NY HEKAHEART HOLDINGS INC C 0 HEMAVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 SCIENTIFIC R&D SZ HEMAVANT SCIENCES HOLDINGS LIMITED C 0 HEMAVANT SCIENCES HOLDINGS LIMITED 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981578379 HOLDING COMPANY UK HEMAVANT SCIENCES LTD C 0 HEMAVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981577750 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 IMMUNOVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 981470927 SCIENTIFIC R&D SZ IMMUNOVANT SCIENCES HOLDINGS LIMITED C 0 IMMUNOVANT SCIENCES HOLDINGS LIMITED 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981468959 HOLDING COMPANY UK IMMUNOVANT SCIENCES LTD C 0 IMMUNOVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981494848 HOLDING COMPANY UK IMMUNOVANT INC C 0 IMMUNOVANT TREASURY INC 1000 PARK FORTY PLAZA STE 210 DURHAM NC 27713 882574422 HOLDING COMPANY NC IMMUNOVANT INC C 0 IMMUNOVANT INC (FKA HEALTH SCIENCES ACQUISITIONS CORPORATION) 1000 PARK FORTY PLAZA STE 210 DURHAM NC 27713 832771572 HOLDING COMPANY NC ROIVANT SCIENCES LTD C 0 IMVT CORPORATION (FKA IMMUNOVANT INC ) 1000 PARK FORTY PLAZA STE 210 DURHAM NC 27713 831251299 SCIENTIFIC R&D NC IMMUNOVANT SCIENCES HOLDINGS LIMITED C 0 IZANA BIOSCIENCE LIMITED 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB HOLDING COMPANY UK KINEVANT LTD C 0 KINEVANT LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981495584 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 KINEVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 981527962 SCIENTIFIC R&D SZ KINEVANT SCIENCES HOLDINGS LIMITED C 0 KINEVANT SCIENCES HOLDINGS LIMITED 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981527842 HOLDING COMPANY UK KINEVANT SCIENCES LTD C 0 KINEVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981494851 HOLDING COMPANY UK KINEVANT LTD C 0 KINEVANT SCIENCES INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 833172270 SCIENTIFIC R&D NY KINEVANT SCIENCES HOLDINGS LIMITED C 0 LYSOVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 981527959 SCIENTIFIC R&D SZ HEMAVANT SCIENCES GMBH C 0 LYSOVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981494841 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 METAVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981463971 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 PHARMAVANT 10 INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 874143208 SCIENTIFIC R&D NY ROIVANT SCIENCES INC C 0 PHARMAVANT 9 LTD C/O CONYERS CORPORATE SERVICES LIMI HAMILTON BD HM11 HOLDING COMPANY BD ROIVANT SCIENCES LTD C 0 PRIMAVANT LTD C/O CONYERS CORPORATE SERVICES LIMI HAMILTON BD HM11 981527381 HOLDING COMPANY BD ROIVANT SCIENCES LTD C 0 PRIOVANT HOLDINGS INC 1007 SLATER ROAD SUITE 250 DURHAM NC 27703 871233821 BIOTECHNOLOGY R&D NC ROIVANT SCIENCES LTD C 0 PRIOVANT THERAPEUTICS INC 1007 SLATER ROAD SUITE 250 DURHAM NC 27703 871508551 BIOTECHNOLOGY R&D NC PRIOVANT HOLDINGS INC C 0 PULMOVANT INC 303 WYMAN ST SUITE 300 WALTHAM MA 02451 923322345 SCIENTIFIC R&D MA ROIVANT SCIENCES LTD C 0 PULMOVANT SCIENCES INC 303 WYMAN ST SUITE 300 WALTHAM MA 02451 331607074 SCIENTIFIC R&D MA PULMOVANT INC C 0 RESPIVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981463960 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 ROIVANT DISCOVERY INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 862031998 SCIENTIFIC R&D NY ROIVANT SCIENCES INC C 0 ROIVANT MS 2 LTD C/O CONYERS CORPORATE SERVICES LIMI HAMILTON BD HM11 HOLDING COMPANY BD ROIVANT SCIENCES LTD C 0 ROIVANT SCIENCES GMBH VIADUKTSTRASSE 8 BASEL SZ 4051 981506527 SCIENTIFIC R&D SZ ROIVANT SCIENCES HOLDINGS LIMITED C 0 ROIVANT SCIENCES HOLDINGS LIMITED 7TH FL 50 BROADWAY LONDON UK SWIH 0DB 981468948 HOLDING COMPANY UK ROIVANT SCIENCES LTD C 0 ROIVANT SCIENCES IRELAND LIMITED ROCKTWIST HOUSE BLOCK 1 WESTERN BU SHANNON CLARE EI V14 FW97 981530399 SCIENTIFIC R&D EI ROIVANT SCIENCES HOLDINGS LIMITED C 0 ROIVANT SCIENCES LTD 50 BROADWAY 7TH FLOOR LONDON UK SWIH 0DB 981173944 HOLDING COMPANY UK N/A C 0 ROIVANT SCIENCES INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 465630757 SCIENTIFIC R&D NY ROIVANT SCIENCES HOLDINGS LIMITED C 0 ROIVANT TREASURY HOLDINGS INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 824789074 HOLDING COMPANY NY ROIVANT SCIENCES LTD C 0 ROIVANT TREASURY INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 824794439 HOLDING COMPANY NY ROIVANT TREASURY HOLDINGS INC C 0 SAVANT BIO INC 1 PENNSYLVANIA PLAZA 54TH FLOOR NEW YORK NY 10119 332462162 SCIENTIFIC R&D NY ROIVANT SCIENCES LTD C 0 SILICON TX HOLDINGS HK LIMITED UNIT 402 4TH FLOOR FAIRMONT HOUSE ADMIRALITY HONG KONG CH HOLDING COMPANY CH ROIVANT MS 2 LTD C 0 ZEST DERMATOLOGY HOLDINGS INC 1111B S GOVERNORS AVE STE 81554 DOVER DE 19904 881717991 HOLDING COMPANY DE ROIVANT SCIENCES LTD C 0 ZEST DERMATOLOGY INC 1111B S GOVERNORS AVE STE 81554 DOVER DE 19904 881739718 ADMINISTRATIVE SERVICES DE ZEST DERMATOLOGY HOLDINGS INC C 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 ROIVANT SCIENCES LTD E 250000 FMV